Skip to main content

Table 1 Baseline characteristics

From: Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study

 

STEMI N = 4899

NSTEMI N = 5159

Women n = 1214

Men n = 3685

p-value

Women n = 1776

Men n = 3383

p-value

Age, yearsa

71 (60–80)

61 (53–70)

<0.0001

77 (65–85)

67 (57–77)

<0.0001

Smoker/ex-smoker, n (%)b

642 (62.0)

2344 (69.8)

<0.0001

731 (51.0)

1949 (66.1)

<0.0001

Diabetes mellitus, n (%)b

163 (13.4)

465 (12.6)

0.469

323 (18.2)

659 (19.5)

0.246

Previous hyperlipidemia, n (%)b,c

148 (12.2)

421 (11.5)

0.468

207 (11.7)

461 (13.7)

0.041

Previous hypertension, n (%)b

521 (42.9)

1163 (31.6)

<0.0001

892 (50.2)

1320 (39.0)

<0.0001

Previous MI, n (%)b

145 (11.9)

492 (13.4)

0.198

439 (24.7)

956 (28.3)

0.006

Previous PCI or CABG, n (%)b

87 (7.2)

428 (11.6)

<0.0001

267 (15.0)

838 (24.8)

<0.0001

Previous stroke, n (%)b

95 (7.8)

183 (5.0)

0.0002

231 (13.0)

341 (10.1)

0.002

Family history, n (%)b,d

160 (13.3)

606 (16.4)

0.007

158 (8.9)

438 (13.0)

<0.0001

Peripheral artery disease, n (%)b

60 (4.9)

143 (3.9)

0.112

121 (6.8)

258 (7.6)

0.276

  1. MI Myocardial infarction, PCI Percutaneous coronary intervention, CABG Coronary artery bypass grafting
  2. median (25th-75th percentile)
  3. (%) = percent of patients with available information, denominator may vary
  4. Hyperlipidemia defined as treatment with lipid-lowering drugs at time of admission
  5. Coronary artery disease before age 65 years in women, 55 years in men in 1st order relatives